BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 36101742)

  • 1. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
    Li J; Gu X; Gao C; Zhang J
    Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a 7-miRNA signature for predicting the prognosis of patients with lung adenocarcinoma.
    Liu R; Guo Z; Huang J; Li J; Tan Q; Luo Q
    Exp Biol Med (Maywood); 2022 Apr; 247(8):641-657. PubMed ID: 35068222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
    Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
    Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
    Qiu X; Chen Y; Zhu X; Gong Z; Yu F; Zhang P; Song Y; Li H
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1275-1287. PubMed ID: 37116150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.
    Wang W; Liu B; Duan X; Feng X; Wang T; Wang P; Ding M; Zhang Q; Feng F; Wu Y; Yao W; Wang Q; Yang Y
    Comb Chem High Throughput Screen; 2020; 23(2):148-156. PubMed ID: 31976830
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
    Li X; Shi Y; Yin Z; Xue X; Zhou B
    J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identify miRNA-mRNA regulation pairs to explore potential pathogenesis of lung adenocarcinoma.
    Fan X; Zou X; Liu C; Peng S; Zhang S; Zhou X; Zhu J; Zhu W
    Aging (Albany NY); 2022 Oct; 14(20):8357-8373. PubMed ID: 36260870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray data analysis to identify miRNA biomarkers and construct the lncRNA-miRNA-mRNA network in lung adenocarcinoma.
    Song Y; Kelava L; Zhang L; Kiss I
    Medicine (Baltimore); 2022 Sep; 101(36):e30393. PubMed ID: 36086747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker of Pulmonary Inflammatory Response in LUAD: miR-584-5p Targets RAB23 to Suppress Inflammation Induced by LPS in A549 Cells.
    Yang E; Hong Y; Xuan C; Xu J; Ding Q; Zhao S; Ye H; Fan X; Jiang Z; Zhang S; Ding X
    Protein Pept Lett; 2023; 30(10):877-890. PubMed ID: 38093594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma.
    Lin R; Li GS; Gan XY; Peng JX; Feng Y; Wang LT; Zhang CY; Huang KY; Huang SH; Yang L; Kong JL; Zhou HF; Chen G; Huang WY
    Technol Health Care; 2023; 31(5):1691-1707. PubMed ID: 36970920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
    Zhang Q; Luo Y; Zhang S; Huang Q; Liu G
    Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of aberrantly expressed microRNA profiles reveals potential biomarkers of human lung adenocarcinoma progression.
    Sui J; Yang RS; Xu SY; Zhang YQ; Li CY; Yang S; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2017 Oct; 38(4):2453-2463. PubMed ID: 28791371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
    Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
    Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-195-3p is a Novel Prognostic Biomarker Associated with Immune Infiltrates of Lung Adenocarcinoma.
    Lao Y; Li T; Xie X; Chen K; Li M; Huang L
    Int J Gen Med; 2022; 15():191-203. PubMed ID: 35023957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.